Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Sale and Maturity of Investments (2018 - 2020)

Updated

Abvc Biopharma (ABVC) reported Sale and Maturity of Investments - Total of $10,716 for Q4 2020, down 89.7% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Sale and Maturity of Investments (2018 - 2020) Analysis & Trends

For FY2020, Abvc Biopharma posted Sale and Maturity of Investments - Total of $147,804.

  • By year, Sale and Maturity of Investments - Total came in at -$156,372 in FY2018.
  • The Q4 2020 figure ranks as the lowest quarterly Sale and Maturity of Investments - Total since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 10,716.00
Sep 30, 2020 103,788.00
Dec 31, 2018 -470,666.00
Sep 30, 2018 205,475.00
API Access

Abvc Biopharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY